News

The Australian Commission on Safety and Quality in Health Carewill lead a review and update of the guiding principles for medication management in residential aged care facilities and in the community to support the safe and quality use of medicines.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on use of COVID-19 vaccines following review of vaccine safety data and benefits.

The Prime Minister provides an update from today's National Cabinet meeting where the COVID-19 vaccination program was discussed. Find out more.

A presentation with an update on Australia's COVID-19 vaccine rollout is now available to view or download.

The Medicare Benefits Schedule (MBS) Review Committee was established in March 2021 to review electrocardiogram (ECG) items introduced on 1 August 2020, following recommendations from the MBS Review Taskforce.

A statement from the Australian Health Protection Principal Committee (AHPPC) on continuous learning in managed quarantine for international arrivals.

There have been changes to the advice around the COVID-19 vaccines. The Pfizer vaccine is now preferred to the AstraZeneca vaccine for adults aged under 50 years.

Professor Brendan Murphy, Department of Health Secretary and Professor Paul Kelly, Australian Government Chief Medical Officer have released a joint statement about ATAGI's latest clinical advice on the AstraZeneca vaccine.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the AstraZeneca COVID-19 vaccine in response to new vaccine safety concerns.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on COVID-19 vaccination and a reported case of thrombosis.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) for consumers on a specific clotting condition being reported after COVID-19 vaccination

Influenza vaccines through the National Immunisation Program (NIP) became available in April 2021. Timing may be different for your local area. You can order vaccines through the usual channels in your state or territory.

Vaccination against influenza (flu) remains important this year. Flu is a highly contagious viral infection that can cause widespread illness and deaths every year. Vaccination is our best defence against flu viruses.

The Australian Public Service employee census report for 2020 has been released. Read more about the census and Health's results.

The floods affecting New South Wales and Queensland can also impact our health in many ways. Learn more on how you can access medical help you need, and what the Australian Government is doing to support your health during this time.

The Australian Government is providing $3.2 million for the fourth and final round of the $45 million BioMed Tech Horizons program. This program has been successful in bringing cutting edge medical devices to market.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) for health care providers on suitability of COVID-19 vaccination in people with history of clotting conditions.

The Australian Government is providing $2.6 million for the latest information technology to improve the lives of people who have survived brain cancer.

This statement from the Australian Technical Advisory Group on Immunisation (ATAGI) updates advice previous provided on 16 March. It follows the European Medicines Agency (EMA) safety review of the AstraZeneca COVID-19 vaccine.

Vaccination against influenza remains important this year. Vaccination experts recommend influenza vaccination for all people aged 6 months and over. The National Immunisation Program (NIP) funds influenza vaccines for people most at risk.

COVID-19 vaccination appointments will be available at GP-led respiratory clinics from 19 March 2021. Find out more.

The Australian Government has announced a $15 million competitive grant round to kick start clinical trials exploring the use of combination therapies to treat mental illnesses.

A new Medical Research Future Fund (MRFF) grant opportunity is supporting Australian researchers to lead, and participate in, international collaborative clinical trials.

Australians eligible for Phase 1b will be able to find a vaccination provider through the new national vaccination information and location service.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding overnight decisions in Europe suspending the use of the AstraZeneca vaccine.